NDC Product
Human Prescription DrugPertzye NDC 59767-004
- Generic Name
- Pancrelipase
- Dosage Form
- Capsule, Delayed Release
- Route
- Oral
- Marketing
- BLA
Active Listing
Pertzye 4000 UNT / 15,125 UNT / 14,375 UNT Delayed Release Oral Capsule
RxNorm 1543006 NDC Crossover
NDC Directory Crossover & Product Mapping
The following National Drug Codes (NDCs) are directly associated with the clinical concept for Pertzye 4000 UNT / 15,125 UNT / 14,375 UNT Delayed Release Oral Capsule (RxCUI 1543006). This crossover tool provides a verified mapping between standardized RxNorm clinical drug definitions and the specific manufactured products listed in the FDA NDC directory.
Healthcare professionals, pharmacists, and data analysts use this list to identify various brand names, labelers, and commercial packaging variations linked to this semantic clinical drug concept. Each entry below represents a commercial product that fulfills the requirements of this specific clinical identifier.
